ArticleArquivos de neuro-psiquiatria2026
Association between alpha 1-antitrypsin levels and intracranial aneurysms: a case-control study.
Article in Arquivos de neuro-psiquiatria, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Alpha 1-antitrypsin (A1AT) helps maintain vascular-wall integrity, but its role in the formation and rupture of intracranial aneurysms is unclear. Objective: To compare A1AT levels between patients with ruptured and unruptured intracranial aneurysms and assess the associations with vasospasm and functional outcomes. Methods: We retrospectively analyzed the medical records of patients who had serum A1AT levels measured between 2018 and 2022 during routine outpatient evaluations. The sample included 233 patients with unruptured intracranial aneurysms, 114 with ruptured aneurysms, and 55 controls with intracranial arteriovenous malformations (AVMs), but without aneurysms. Results: The mean A1AT levels were 134.9 ± 23.3 mg/dL in the unruptured group, 132.1 ± 20.3 mg/dL in the ruptured group, and 132 ± 19 mg/dL in the controls. The A1AT levels did not exhibit a significant association with the presence of intracranial aneurysms when compared to the levels of the control group (odds ratio [OR]: 1.07; 95%CI: 0.93-1.25; Conclusion: The A1AT levels did not differ between the groups with ruptured and unruptured aneurysms, neither were they associated with vasospasm nor functional outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.